Results 181 to 190 of about 33,585,029 (332)

The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). [PDF]

, 1910
WILLIAM B. COLEY
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Physiological Studies of the Rice Plant with Special Reference to the Crop Failure Caused by the Occurrence of Unseasonable Low Temperature. [V]. Anthesis and Fertilization as Affected by the Low Temperature Treatment on Heading

, 1940
Hirosi TERAO, Yosio OTANI, Y. Doi
openalex   +2 more sources

Gradient Elution Analysis. I. A General Treatment. [PDF]

, 1952
Rikard Alm, Richard J. Williams, Arne Tiselius, J. Plı́va, Jörgine Stene Sörensen, Nils Andreas Sörensen   +5 more
openalex   +1 more source

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

A multistate transition model for survival estimation in randomized trials with treatment switching and a cured subgroup. [PDF]

BMC Med Res Methodol
Hu H, Wang L, Wu K, Ge W, Xia J, Li C.
europepmc   +1 more source

Mechanical System for Record Keeping of Morbidity, Treatment-Progress and Control of Venereal Diseases

, 1940
Lida J. Usilton
openalex   +1 more source

Causes and Treatment of Congenital Eccentric Nystagmus [PDF]

, 1953
Jonathan Anderson
openalex   +1 more source

Treatment of Pneumonia [PDF]

, 1941
Casey, John F.
core   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source